Janssen Alzheimer Immunotherapy Research & Development, LLC
Overview
Janssen Alzheimer Immunotherapy Research & Development, LLC focuses on the research and development of therapeutic solutions for Alzheimer's disease. It is a subsidiary of Johnson & Johnson, a leading global healthcare company.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Janssen Alzheimer Immunotherapy Research & Development, LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Janssen Alzheimer Immunotherapy Research & Development, LLC? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.